AIM ImmunoTech Inc
Biotechnology
Healthcare
AIM
47.83M shares
NYSE MKT US
open
1.34
52 week high
2.82
high
1.43
52 week low
1.32
previous Close
1.33
P/E ratio
-18
market cap
75.60M
div yield
0
net incoming
-3.83M
34.89 %
net profit margin
-11593.94 %
13953.00 %
operating incoming
72.00K
101.94 %
net change in cash
-3.79M
50.29 %
cash on hand
37.35M
-9.22 %
cost of revenue
157K
-43.73 %
top